Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-28T00:36:59.610Z Has data issue: false hasContentIssue false

Lack of false-positive results for Clostridioides difficile toxins A and B using two commercial enzyme immunoassays in pediatric patients

Published online by Cambridge University Press:  29 April 2019

Aakash B. Balaji
Affiliation:
Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Joseph S. Sichel
Affiliation:
Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois
Larry K. Kociolek*
Affiliation:
Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois Division of Pediatric Infectious Diseases, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois
*
*Author for correspondence: Larry K. Kociolek, Email: [email protected]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Brief
Copyright
© 2019 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Burnham, CA, Dubberke, ER, Kociolek, LK, Polage, CR, Riley, TV. Clostridium difficile-diagnostic and clinical challenges. Clin Chem 2016;62:310314.CrossRefGoogle ScholarPubMed
Burnham, CA, Carroll, KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 2013;26:604630.CrossRefGoogle ScholarPubMed
Polage, CR, Gyorke, CE, Kennedy, MA, et al. Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med 2015;175: 17921801.CrossRefGoogle ScholarPubMed
Planche, TD, Davies, KA, Coen, PG, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis 2013;13:936945.CrossRefGoogle ScholarPubMed
McDonald, LC, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66(7):e1e48.CrossRefGoogle Scholar
Toltzis, P, Nerandzic, MM, Saade, E, et al. High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients. Infect Control Hosp Epidemiol 2012;33:175179.CrossRefGoogle Scholar
Sandora, TJ, Bryant, KK, Cantey, JB, Elward, AM, Yokoe, DS, Bartlett, AH. SHEA neonatal intensive care unit (NICU) white paper series: practical approaches to Clostridioides difficile prevention. Infect Control Hosp Epidemiol 2018;39:11491153.CrossRefGoogle ScholarPubMed
Kociolek, LK, Patel, SJ, Shulman, ST, Gerding, D. Molecular epidemiology of Clostridium difficile infections in children: a retrospective cohort study. Infect Control Hosp Epidemiol 2015;36:445451.CrossRefGoogle ScholarPubMed
Kociolek, LK, Sandora, TJ. National variability in surveillance, testing, and infection prevention for Clostridium difficile infection in pediatric populations. Am J Infect Control 2013;41:933935.CrossRefGoogle ScholarPubMed
Kociolek, LK, Kutty, P, Polgreen, PM, Beekman, SE. Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile in children: an Emerging Infections Network survey. Infect Control Hosp Epidemiol 2019;40:276280.CrossRefGoogle Scholar